Correction: Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies - Top-Institutions - MDSpire

Correction: Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies

  • By

  • Pupu Li

  • Xia Xue

  • Zisen Zhang

  • July 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    Fifth Affiliated Hospital of Zhengzhou University
    Fifth Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan

    Key Differentiators

    • Hematology

  • #4

    Zhengzhou Key Laboratory of Lipid Metabolism and Precision Diagnosis & Treatment in Oncology
    Zhengzhou Key Laboratory of Lipid Metabolism and Precision Diagnosis & Treatment in Oncology

    Zhengzhou, Henan

    Key Differentiators

    • Oncology

  • #5

    Cleveland Clinic Cancer Institute
    Cleveland Clinic Cancer Institute

    Cleveland, OH

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Correction: Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies

  • by Pupu Li, Xia Xue, Zisen Zhang

  • July 8, 2026

Related Content

The use of motion tracking technology to support an exercise intervention for children and young people with cancer: perspectives of users and healthcare professionals in the FORTEe trial

Hope is everything – an hermeneutic phenomenological study on the lived experiences of individuals with adrenocortical carcinoma

Multi-scale information bottleneck with confidence-weighted decision fusion for robust breast ultrasound lesion classification